The AeroVax study will test needle-free vaccines that proved more effective than traditional injected vaccines in pre-clinical studies and the Phase 1 trial.
The inhaled aerosol vaccine is far more effective at inducing protective immune responses than traditional injections, targeting the lungs and upper airways where viruses first enter the body and providing long-lasting protection against respiratory infections.
Seven McMaster-led research projects are receiving funding from the Clinical Trials Fund, designed to enhance Canada’s clinical trials ecosystem from discovery to implementation.
McMaster logo
McMaster logo
